EUVIMEDEUVIMED entdecken
Multizentrische Studie

Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure

Eugene S J Tan, Siew Pang Chan, Oi Wah Liew, Jenny P C Chong, Kui Toh Gerard Leong, Poh Shuan Daniel Yeo, Hean Yee Ong, Fazlur Jaufeerally, David Sim, Lieng Hsi Ling, Carolyn S P Lam, A Mark Richards

JACC: Heart Failure · 2024

DOI: 10.1016/j.jchf.2023.09.011 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Eugene S J Tan und 11 weiteren Autor:innen. Beteiligte Einrichtung: National University Heart Centre, Singapore; Yong Loo Lin School of Medicine, National University Singapore, Singapore. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Natriuretic peptide (NP) elevations are prognostic in heart failure (HF), but relative atrial NP deficiency in acute HF has been suggested. OBJECTIVES: The authors compared plasma concentrations and relative strength of associations of A- and B-type NPs with cardiac structure/function and clinical outcomes in HF. METHODS: Midregional pro-atrial natriuretic peptide (MR-proANP), B-type natriuretic peptide (BNP), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were measured in patients with compensated HF in a prospective, multicenter study. The primary outcome was a composite of HF-hospitalization or all-cause mortality. Secondary outcomes included individual primary outcome components and cardiovascular admission. RESULTS: Among 1,278 patients (age 60.1 ± 12.1 years, 82% men, left ventricular ejection fraction [LVEF] 34% ± 14%), median concentrations of MR-proANP were 990 pg/mL (Q1-Q3: 557-1,563 pg/mL), NT-proBNP 1,648 pg/mL (Q1-Q3: 652-3,960 pg/mL), and BNP 291 pg/mL (Q1-Q3: 103-777 pg/mL). No subpopulation with inappropriately low MR-proANP (relative to BNP/NT-proBNP) was observed. Clinical event rates were similar for biomarker tertiles. Increments in MR-proANP exhibited steeper associations with concurrent shifts in left ventricular size, diastolic indexes and LVEF than BNP/NT-proBNP at baseline and serially (P < 0.05), and lower odds of beneficial left ventricular reverse remodeling: OR: 0.35 (95% CI: 0.18-0.70). In single-biomarker models, MR-proANP(log10) was associated with the highest hazard (4 to 6 times) for each outcome. In multimarker models, independent associations were observed for the primary outcome (MR-proANP and NT-proBNP), HF-hospitalization and cardiovascular admission (MR-proANP only), and all-cause mortality (NT-proBNP only) (P < 0.05). The discriminative value of MR-proANP was superior to BNP/NT-proBNP (HF-hospitalization) and BNP (primary outcome) (P < 0.05). CONCLUSIONS: MR-proANP was not inappropriately low relative to concurrent BNP/NT-proBNP values. Proportional increments in MR-proANP were more pronounced than for B-peptides for given decrements in cardiac structure/function. MR-proANP offered greater independent predictive power overall.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMaleHumansMiddle AgedAgedFemaleNatriuretic Peptide, BrainAtrial Natriuretic FactorProspective StudiesStroke VolumeVentricular Function, LeftPrognosisBiomarkersPeptide Fragments

Stichwörter der Autor:innen

B-type natriuretic peptideN-terminal pro-BNPbiomarkersheart failuremidregional pro–atrial natriuretic peptide

Substanzen

Natriuretic Peptide, BrainAtrial Natriuretic FactorBiomarkersPeptide Fragments

Autor:innen und Institutionen

  • National University Heart Centre, Singapore; Yong Loo Lin School of Medicine, National University Singapore, Singapore.
  • Yong Loo Lin School of Medicine, National University Singapore, Singapore.
  • Department of Cardiology, Changi General Hospital, Singapore.
  • Department of Cardiology, Tan Tock Seng Hospital, Singapore.
  • Department of Cardiology, Khoo Teck Puat Hospital, Singapore.
  • Department of Internal Medicine, Singapore General Hospital, Singapore; Duke-NUS Graduate Medical School, Singapore.

Förderung

  • Bayer

Zitieren

APA

Tan, E. S. J., Chan, S. P., Liew, O. W., Chong, J. P. C., Gerard Leong, K. T., Daniel Yeo, P. S., Ong, H. Y., Jaufeerally, F., Sim, D., Ling, L. H., Lam, C. S. P., & Richards, A. M. (2024). Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.09.011

Vancouver

Tan ESJ, Chan SP, Liew OW, Chong JPC, Gerard Leong KT, Daniel Yeo PS, et al. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2023.09.011

BibTeX
@article{Tan2024,
  author = {Tan, Eugene S J and Chan, Siew Pang and Liew, Oi Wah and Chong, Jenny P C and Gerard Leong, Kui Toh and Daniel Yeo, Poh Shuan and Ong, Hean Yee and Jaufeerally, Fazlur and Sim, David and Ling, Lieng Hsi and Lam, Carolyn S P and Richards, A Mark},
  title = {Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure},
  journal = {JACC: Heart Failure},
  year = {2024},
  doi = {10.1016/j.jchf.2023.09.011}
}
Kostenlos starten →